MEDACTA GROUP SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 110.6 CHF | +2.03% |
|
0.00% | -11.94% |
| Mar. 13 | Medacta Group SA Proposes Distribution | CI |
| Mar. 13 | Medacta Group SA Provides Earnings Guidance for the Year 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,334 | 1,615 | 2,743 | 2,078 | 2,697 | 2,257 | - | - |
| Enterprise Value (EV) 1 | 1,439 | 1,698 | 2,808 | 2,190 | 2,697 | 2,408 | 2,399 | 2,382 |
| P/E ratio | 113 x | 43.6 x | 53.2 x | 45 x | 57 x | 30.6 x | 26.7 x | 22.4 x |
| Yield | - | - | 0.39% | 0.52% | - | 0.71% | 0.81% | 0.99% |
| Capitalization / Revenue | 4.29 x | 5.34 x | 7.55 x | 4.75 x | 5.28 x | 3.79 x | 3.39 x | 3.02 x |
| EV / Revenue | 4.63 x | 5.61 x | 7.73 x | 5.01 x | 5.28 x | 4.04 x | 3.61 x | 3.19 x |
| EV / EBITDA | 15.7 x | 19.3 x | 26.2 x | 18.2 x | 20.1 x | 15.2 x | 13.1 x | 11.4 x |
| EV / FCF | 1,615 x | 66.9 x | 371 x | 101 x | - | 67.6 x | 93.1 x | 66.9 x |
| FCF Yield | 0.06% | 1.5% | 0.27% | 0.99% | - | 1.48% | 1.07% | 1.5% |
| Price to Book | 10.8 x | 9.8 x | 12.1 x | 7.56 x | - | 5.75 x | 4.91 x | 4.15 x |
| Nbr of stocks (in thousands) | 20,000 | 20,000 | 19,997 | 19,979 | 19,958 | 19,928 | - | - |
| Reference price 2 | 66.68 | 80.74 | 137.1 | 104.0 | 135.1 | 113.3 | 113.3 | 113.3 |
| Announcement Date | 4/6/20 | 3/30/21 | 3/11/22 | 3/17/23 | 3/13/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 310.6 | 302.5 | 363.1 | 437.1 | 510.8 | 595.9 | 665.4 | 746.5 |
| EBITDA 1 | 91.5 | 88.1 | 107.1 | 120.4 | 134.2 | 158.7 | 182.6 | 209 |
| EBIT 1 | 57.81 | 51.08 | 66.68 | 68.94 | 75.72 | 93.33 | 107.5 | 126.1 |
| Operating Margin | 18.61% | 16.88% | 18.36% | 15.77% | 14.82% | 15.66% | 16.16% | 16.89% |
| Earnings before Tax (EBT) 1 | 13.63 | 39.9 | - | 54.79 | 58.73 | 89.54 | 96.77 | 116.8 |
| Net income 1 | 11.86 | 37.1 | 51.52 | 46.25 | 47.36 | 72.84 | 84.37 | 98.13 |
| Net margin | 3.82% | 12.26% | 14.19% | 10.58% | 9.27% | 12.22% | 12.68% | 13.14% |
| EPS 2 | 0.5900 | 1.850 | 2.580 | 2.310 | 2.370 | 3.704 | 4.235 | 5.059 |
| Free Cash Flow 1 | 0.891 | 25.4 | 7.57 | 21.6 | - | 35.63 | 25.78 | 35.62 |
| FCF margin | 0.29% | 8.4% | 2.08% | 4.94% | - | 5.98% | 3.87% | 4.77% |
| FCF Conversion (EBITDA) | 0.97% | 28.83% | 7.07% | 17.93% | - | 22.45% | 14.11% | 17.04% |
| FCF Conversion (Net income) | 7.51% | 68.46% | 14.69% | 46.7% | - | 48.91% | 30.55% | 36.3% |
| Dividend per Share 2 | - | - | 0.5400 | 0.5400 | - | 0.8016 | 0.9124 | 1.117 |
| Announcement Date | 4/6/20 | 3/30/21 | 3/11/22 | 3/17/23 | 3/13/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales | 159 | 134.8 | 167.7 | 177.5 | 185.6 | 211.3 | - | 255.1 | - |
| EBITDA 1 | 44.5 | 32.05 | 56 | 56.58 | - | 58.05 | - | 71.9 | 62.26 |
| EBIT | 27.1 | 13.3 | 37.78 | 38.06 | 28.62 | - | 35.22 | - | - |
| Operating Margin | 17.05% | 9.86% | 22.53% | 21.45% | 15.42% | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | - | - | - | - | - | - | 36.2 | 22.53 |
| Net income 1 | 0.563 | 9.684 | 27.42 | 29.74 | 21.78 | - | 20.62 | 29.14 | 18.22 |
| Net margin | 0.35% | 7.18% | 16.35% | 16.75% | 11.73% | - | - | 11.42% | - |
| EPS | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - |
| Announcement Date | 4/6/20 | 9/7/20 | 3/30/21 | 9/10/21 | 3/11/22 | 9/9/22 | 3/17/23 | 9/21/23 | 3/13/24 |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 106 | 83.3 | 65.3 | 112 | - | 151 | 143 | 125 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.154 x | 0.9455 x | 0.6093 x | 0.9265 x | - | 0.9501 x | 0.7803 x | 0.598 x |
| Free Cash Flow 1 | 0.89 | 25.4 | 7.57 | 21.6 | - | 35.6 | 25.8 | 35.6 |
| ROE (net income / shareholders' equity) | 42.5% | 25.8% | 30.1% | 18.5% | - | 19.9% | 20.4% | 20.2% |
| ROA (Net income/ Total Assets) | 11.6% | 8.68% | 12.6% | 8.61% | - | - | - | - |
| Assets 1 | 102.3 | 427.4 | 408.9 | 536.9 | - | - | - | - |
| Book Value Per Share 2 | 6.160 | 8.240 | 11.30 | 13.80 | - | 19.70 | 23.10 | 27.30 |
| Cash Flow per Share 2 | - | 2.980 | 2.700 | 3.680 | - | 6.110 | 6.540 | 7.720 |
| Capex 1 | 41.5 | 34.2 | 52 | 63.2 | - | 81.9 | 88 | 104 |
| Capex / Sales | 13.35% | 11.31% | 14.33% | 14.45% | - | 13.74% | 13.23% | 13.97% |
| Announcement Date | 4/6/20 | 3/30/21 | 3/11/22 | 3/17/23 | 3/13/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
113.3
EUR
Average target price
147
EUR
Spread / Average Target
+29.78%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.94% | 2.41B | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.36% | 26.25B | |
| +2.07% | 26.48B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- MOVE Stock
- Financials Medacta Group SA
